Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Remifentanil Induced Hyperalgesia
NCT02992938Phase 4Completed
- Sponsor
- Universidad de Chile
- Start
- Dec 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in opioid-induced hyperalgesia (OIH), sponsored by Universidad de Chile. Started Dec 2016; status: completed.
02
Drugs
acetazolamide
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on NCT02992938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992938.